Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gambacciani

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 9, 2004
The study with a million women (and hopefully fewer mistakes)M Gambacciani, A R Genazzani
Climacteric : the Journal of the International Menopause Society|March 26, 2002
Controversial issues in climacteric medicine I. Cardiovascular disease and hormone replacement therapy. International Menopause Society Expert Workshop. 13-16 October 2000, royal society of medicine, London, UKA R Genazzani, M Gambacciani,
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 1, 1994
Autonomous gonadotropin release from the human pituitary in vitro and factors influencing this secretionW G Rossmanith, M Gambacciani
Climacteric : the Journal of the International Menopause Society|June 2, 2015
Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopauseM Gambacciani, M Levancini, M Cervigni
Climacteric : the Journal of the International Menopause Society|January 11, 2019
Hormone replacement therapy and prevention of chronic conditionsM Gambacciani, A Cagnacci, S Lello
Maturitas|June 23, 2020
Reflections and recommendations on the COVID-19 pandemic: Should hormone therapy be discontinued?A Cagnacci, G Bonaccorsi, M Gambacciani, et al.
Climacteric : the Journal of the International Menopause Society|June 8, 2002
Low-dose hormone replacement therapy: effects on boneM Gambacciani, P Monteleone, A R Genazzani
FEBS Letters|July 9, 1984
Some properties of a purinergic receptor solubilized from human uterus membranesS Ronca-Testoni, P Galbani, M Gambacciani
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|August 6, 2004
Estrogens and women's health: a scary or a fairy tale?Andrea R Genazzani, M Gambacciani, T Simoncini
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|November 22, 2005
Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17beta-estradiol and trimegestone versus two regimens combining 1 or 2 mg 17beta-estradiol and norethisterone acetateM Gambacciani, D Spielmann, A R Genazzani
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 9, 2004
The study with a million women (and hopefully fewer mistakes)M Gambacciani, A R Genazzani
Climacteric : the Journal of the International Menopause Society|March 26, 2002
Controversial issues in climacteric medicine I. Cardiovascular disease and hormone replacement therapy. International Menopause Society Expert Workshop. 13-16 October 2000, royal society of medicine, London, UKA R Genazzani, M Gambacciani,
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 1, 1994
Autonomous gonadotropin release from the human pituitary in vitro and factors influencing this secretionW G Rossmanith, M Gambacciani
Climacteric : the Journal of the International Menopause Society|June 2, 2015
Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopauseM Gambacciani, M Levancini, M Cervigni
Climacteric : the Journal of the International Menopause Society|January 11, 2019
Hormone replacement therapy and prevention of chronic conditionsM Gambacciani, A Cagnacci, S Lello
Maturitas|June 23, 2020
Reflections and recommendations on the COVID-19 pandemic: Should hormone therapy be discontinued?A Cagnacci, G Bonaccorsi, M Gambacciani, et al.
Climacteric : the Journal of the International Menopause Society|June 8, 2002
Low-dose hormone replacement therapy: effects on boneM Gambacciani, P Monteleone, A R Genazzani
FEBS Letters|July 9, 1984
Some properties of a purinergic receptor solubilized from human uterus membranesS Ronca-Testoni, P Galbani, M Gambacciani
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|August 6, 2004
Estrogens and women's health: a scary or a fairy tale?Andrea R Genazzani, M Gambacciani, T Simoncini
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|November 22, 2005
Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17beta-estradiol and trimegestone versus two regimens combining 1 or 2 mg 17beta-estradiol and norethisterone acetateM Gambacciani, D Spielmann, A R Genazzani
Pageof 12